Año 2023 / Volumen 115 / Número 12
Original
Value of CRP/albumin ratio as a prognostic marker of acute pancreatitis: a retrospective study

707-712

DOI: 10.17235/reed.2023.9345/2022

Jean Félix Piñerúa-Gonsálvez, María Lourdes Ruiz Rebollo, Rosanna del Carmen Zambrano-Infantino, María Antonella Rizzo-Rodríguez, Luis Fernández-Salazar,

Resumen
Introduction: the C-reactive protein (CRP) to albumin ratio is an inflammatory marker that has shown promise in the prognosis of critically ill patients. This study is aimed to assess the value of CRP/albumin ratio to predict severity in acute pancreatitis. Methods: a retrospective study was performed using a prospectively collected database of patients diagnosed with AP admitted to the Department of Gastroenterology between March 2014 and December 2021. Results: among 722 patients included in the study, 78.67 % had mild, 15.65 % had moderately severe, and 5.67 % had severe acute pancreatitis. The CRP/albumin ratio was significantly associated with severe AP (OR 1.02; 95 % CI: 1.01-1.03; p < 0.001), and each ten-unit increase in the ratio was associated with a 20 % increased likelihood of severe acute pancreatitis. The area under the ROC curve (AUC) value of the CRP/albumin ratio in severe acute pancreatitis was 0.68 (95 % CI: 0.58-0.77), which was higher than that of the Ranson criteria (0.62). The optimal cut-off value for predicting severe acute pancreatitis was 7.51, with a sensitivity of 63.4 % and specificity of 65.6 %. Conclusions: despite its low sensitivity and specificity, the CRP/albumin ratio could be used as a complementary marker to the current scoring systems for the initial assessment of acute pancreatitis prognosis. It is easily obtainable and can provide additional prognostic information to clinicians.
Resumen coloquial
The present study investigated the potential of C-reactive protein (CRP) to albumin ratio in predicting the severity of acute pancreatitis. Data from 722 patients diagnosed with acute pancreatitis were analyzed, revealing a significant association between the CRP/albumin ratio and severe cases of the condition. Each 10-unit increase in the ratio was found to be associated with a 20% higher likelihood of developing severe pancreatitis. A comparison was made between the performance of the CRP/albumin ratio and the commonly used Ranson criteria scoring system, demonstrating that the ratio had a higher predictive value for severe acute pancreatitis. An optimal cut-off value of 7.51 was identified for the CRP/albumin ratio in identifying severe acute pancreatitis. At this threshold, the test showed a sensitivity of 63.4% and specificity of 65.6%. Despite limitations in terms of sensitivity and specificity, the CRP/albumin ratio could serve as a supplementary tool alongside existing scoring systems in the initial assessment of acute pancreatitis. Obtained easily through a blood test, the ratio provides additional prognostic information, assisting clinicians in evaluating the severity of the condition and making informed treatment decisions. Further research is required to validate these findings and evaluate the clinical utility of the CRP/albumin ratio in managing acute pancreatitis.
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Artículos relacionados

Carta

Anemia can predict organ failure in acute pancreatitis

DOI: 10.17235/reed.2023.9700/2023

Editorial

Acute pancreatitis: an opportunity for gastroenterology hospitalists?

DOI: 10.17235/reed.2022.8573/2022

Imagen en Patología Digestiva

Endoscopic necrosectomy – when the gastroenterologist faces his greatest nightmare.

DOI: 10.17235/reed.2021.8403/2021

Imagen en Patología Digestiva

Wunderlich syndrome secondary to severe acute pancreatitis

DOI: 10.17235/reed.2021.8184/2021

Carta

Daño pancreático: pancreatitis aguda en pacientes COVID-19

DOI: 10.17235/reed.2021.7807/2021

Carta

Pancreatic injury in COVID-19: pathogenesis and challenges

DOI: 10.17235/reed.2020.7541/2020

Carta

SARS-CoV-2 and acute pancreatitis: a new etiological agent?

DOI: 10.17235/reed.2020.7481/2020

Carta

Acute pancreatitis associated with levofloxacin

DOI: 10.17235/reed.2020.6652/2019

Imagen en Patología Digestiva

Endoscopic therapy in disconnected duct syndrome: re-connecting the duct

DOI: 10.17235/reed.2020.6650/2019

Imagen en Patología Digestiva

Perforación de colon por fistulización de pseudoquiste pancreático

DOI: 10.17235/reed.2018.5884/2018

Imagen en Patología Digestiva

A rare case of acute obstructive suppurative pancreatic ductitis associated with ERCP

DOI: 10.17235/reed.2018.5756/2018

Carta al Editor

A patient with Castleman’s disease mimicking acute pancreatitis

DOI: 10.17235/reed.2017.5120/2017

Editorial

Acute-on-chronic liver failure: a time to step forward

DOI: 10.17235/reed.2017.5054/2017

Carta al Editor

Genetics in idiopathic pancreatitis and acute recurrent pancreatitis

DOI: 10.17235/reed.2017.4632/2016

Carta al Editor

Hematoma gástrico intramural en el contexto de una pancreatitis aguda

DOI: 10.17235/reed.2017.4494/2016

Caso Clínico

Pancreatitits aguda necroticohemorrágica en malaria falciparum

DOI: 10.17235/reed.2015.3768/2015

Instrucciones para citar
Piñerúa-Gonsálvez J, Ruiz Rebollo M, Zambrano-Infantino R, Rizzo-Rodríguez M, Fernández-Salazar L. Value of CRP/albumin ratio as a prognostic marker of acute pancreatitis: a retrospective study. 9345/2022


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 769 veces.
Este artículo ha sido descargado 163 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 10/11/2022

Aceptado: 01/07/2023

Prepublicado: 04/08/2023

Publicado: 12/12/2023

Tiempo de revisión del artículo: 225 días

Tiempo de prepublicación: 267 días

Tiempo de edición del artículo: 397 días


Compartir
Este artículo aun no tiene valoraciones.
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas